PARK2 mutations and clinical features in a Chinese population with early-onset Parkinson’s disease
✍ Scribed by Daniel Kam Yin Chan; Vincent Mok; Ping Wing Ng; Jonas Yeung; John B. Kwok; Zhi Ming Fang; Raymond Clarke; Lawrence Wong; Peter R. Schofield; Nobutaka Hattori
- Publisher
- Springer
- Year
- 2008
- Tongue
- English
- Weight
- 151 KB
- Volume
- 115
- Category
- Article
- ISSN
- 1435-1463
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Mutations in __LRRK2__ (__leucine‐rich repeat kinase 2__) have been associated with autosomal dominant Parkinson's disease (PD) and cluster in several 3′ exons of the gene. The majority of mutations have been detected in late‐onset cases (age at onset >50 years). We screened 5 of the 51
## Abstract We determined the prevalence of two common leucine‐rich repeat kinase 2 (LRRK2) gene mutations in Australian patients with Parkinson's disease (PD). Of 830 affected patients, eight were heterozygous for the G2019S mutation, and two were heterozygous for the R1441H (4,322 G > A) mutation
## Abstract Mutations of __PLA2G6__ gene have been lately proposed to be the causative gene for PARK14 in patients with autosomal recessive young‐onset parkinsonism (YOPD). The role of __PLA2G6__ mutations as a risk factor for Parkinson's disease is not clear. To study the __PLA2G6__ mutations in P
## Abstract A multiethnic series of patients with early‐onset Parkinson's disease (EOP) was studied to assess the frequency and nature of __parkin__/PARK2 gene mutations and to investigate phenotype–genotype relationships. Forty‐six EOP probands with an onset age of <45 years, and 14 affected relat